Skip to main content
Log in

Relative pre- and postsynaptic potencies of α-adrenoceptor agonists in the rabbit pulmonary artery

  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

The rabbit pulmonary artery contains postsynaptic α-adrenoceptors which mediate smooth muscle contraction; its noradrenergic nerves contain presynaptic α-adrenoceptors which mediate inhibition of the release of the transmitter evoked by nerve impulses. Dose-response curves for the pre- and postsynaptic effects of eight α-receptor agonists were determined on superfused strips of the artery in the presence of cocaine, corticosterone and propranolol.

  1. 1.

    According to the concentrations which caused 20% of the maximal contraction (EC20 post), the postsynaptic rank order of potency was: adrenaline > noradrenaline > oxymetazoline > naphazoline > phenylephrine > tramazoline >α-methylnoradrenaline > methoxamine. The pA2 values of phentolamine against oxymetazoline, phenylephrine, α-methylnoradrenaline and methoxamine were 7.43, 7.48, 7.59 and 7.69, respectively.

  2. 2.

    For the investigation of presynaptic effects, the arteries were preincubated with 3H-noradrenaline. All agonists inhibited the overflow of tritium evoked by transmural sympathetic nerve stimulation. According to the concentrations which reduced the stimulation-induced overflow by 20% (EC20 pre), the rank order of potency was: adrenaline > oxymetazoline > tramazoline > α-methylnoradrenaline > noradrenaline > naphazoline > phenylephrine > methoxamine. 10−5 M phentolamine shifted the presynaptic dose-response curves for noradrenaline and oxymetazoline to the right.

  3. 3.

    The ratio EC20 pre/EC20 post was calculated for each agonist as an index of its relative post- and presynaptic potency. According to the ratios, the agonists were arbitrarily classified into three groups. Group 1 (ratio about 30; preferentially postsynaptic agonists) comprised methoxamine and phenylephrine; group 2 (ratio near 1; similar pre- and postsynaptic potencies) comprised noradrenaline, adrenaline and naphazoline; group 3 (ratio below 0.2; preferentially presynaptic agonists) comprised oxymetazoline, α-methylnoradrenaline and tramazoline (as well as clonidine).

  4. 4.

    Preferentially presynaptic and preferentially postsynaptic agonists had opposite effects on the vasoconstrictor response to nerve stimulation. Methoxamine and phenylephrine either did not change or enhanced, but never reduced, the response. In contrast, oxymetazoline, α-methylnoradrenaline and tramazoline at low concentrations selectively inhibited the response to stimulation at low frequency (0.25–2 Hz).

  5. 5.

    It is concluded that α-adrenoceptor agonists vary widely in their relative pre- and postsynaptic potencies, possibly because of structural differences between pre- and postsynaptic α-receptors. Pre- and postsynaptic components contribute to their overall postsynaptic effect in actively transmitting synapses. The preferential activation of presynaptic α-receptors results in α-adrenergic inhibition of synaptic transmission.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Armstrong, J. M., Boura, A. L. A.: Effects of clonidine and guanethidine on peripheral sympathetic nerve function in the pithed rat. Brit. J. Pharmacol. 47, 850–852 (1973)

    Google Scholar 

  • Bevan, J. A., Osher, J. V.: Relative sensitivity of some large blood vessels of the rabbit to sympathomimetic amines. J. Pharmacol. exp. Ther. 150, 370–374 (1965)

    Google Scholar 

  • Dubocovich, M. L., Langer, S. Z.: Negative feed-back regulation of noradrenaline release by nerve stimulation in the perfused cat's spleen: Differences in potency of phenoxybenzamine in blocking the pre- and postsynaptic adrenergic receptors. J. Physiol. (Lond.) 237, 505–519 (1974)

    Google Scholar 

  • Farnebo, L. O., Hamberger, B.: Drug-induced changes in the release of (3H)-noradrenaline from field stimulated rat iris. Brit. J. Pharmacol. 43, 97–106 (1971)

    Google Scholar 

  • Farnebo, L. O., Hamberger, B.: Influence of α- and β-adrenoceptors on the release of noradrenaline from field stimulated atria and cerebral cortex slices. J. Pharm. Pharmacol. 26, 644–646 (1974)

    Google Scholar 

  • Furchgott, R. F.: The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. In: H. Blaschko and E. Muscholl (eds.): Catecholamines. Handbook of Pharmacology, Vol. XXXIII, pp. 283–335. Berlin-Heidelberg-New York: Springer 1972

    Google Scholar 

  • Häggendal, J., Johansson, B., Jonason, J., Ljung, B.: Effects of phenoxybenzamine on transmitter release and effector response in the isolated portal vein. J. Pharm. Pharmacol. 24, 161–164 (1972)

    Google Scholar 

  • Hughes, J.: Inhibition of noradrenaline release by lysergic acid diethylamide. Brit. J. Pharmacol. 49, 706–708 (1973)

    Google Scholar 

  • Kirpekar, S. M., Furchgott, R. F., Wakade, A. R., Prat, J. C.: Inhibition by sympathomimetic amines of the release of norepinephrine evoked by nerve stimulation in the cat spleen. J. Pharmacol. exp. Ther. 187, 529–538 (1973)

    Google Scholar 

  • Kirpekar, S. M., Puig, M.: Effect of flow-stop on noradrenaline release from normal spleens and spleens pretreated with cocaine, phentolamine or phenoxybenzamine. Brit. J. Pharmacol. 43, 359–369 (1971)

    Google Scholar 

  • Kobinger, W.: Über den Wirkungsmechanismus einer neuen antihypertensiven Substanz mit Imidazolinstruktur. Naunyn-Schmiedebergs Arch. Pharmak. exp. Path. 258, 48–58 (1967)

    Google Scholar 

  • Langer, S. Z.: Presynaptic regulation of catecholamine release. Biochem. Pharmacol. 23, 1793–1800 (1974)

    Google Scholar 

  • Langer, S. Z., Adler, E., Enero, M. A., Stefano, F. J. E.: The role of the alpha receptor in regulating noradrenaline overflow by nerve stimulation. Proc. intern. Union Physiol. Sci. 9, 335 (1971)

    Google Scholar 

  • Malik, K. U., Muscholl, E.: Effect of sympathomimetic amines on the response of the perfused mesenteric artery preparation to adrenergic nerve stimulation. Arzneimittel-Forsch. 19, 1574–1579 (1969)

    Google Scholar 

  • Mujié, M., van Rossum, J. M.: Comparative pharmacodynamics of sympathomimetic imidazolines; studies on intestinal smooth muscle of the rabbit and the cardiovascular system of the cat. Arch. int. Pharmacodyn. 155, 432–449 (1965)

    Google Scholar 

  • Pacha, W., Salzmann, R., Scholtysik, G.: Inhibitory effects of clonidine and BS 100–141 on responses to sympathetic nerve stimulation in cats and rabbits. Brit. J. Pharmacol. 53, 513–516 (1975)

    Google Scholar 

  • Robson, R. D., Antonacelo, M. J.: Effect of clonidine on responses to cardiac nerve stimulation as a function of impulse frequency and stimulus duration in vagotomized dogs. Europ. J. Pharmacol. 29, 182–186 (1974)

    Google Scholar 

  • Scriabine, A., Stavorski, J. M.: Effect of clonidine on cardiac acceleration in vagotomized dogs. Europ. J. Pharmacol. 24, 101–104 (1973)

    Google Scholar 

  • Scriabine, A., Stavorski, J., Wenger, H. C., Torchiana, M. L., Stone, C. A.: Cardiac slowing effects of clonidine (ST-155) in dogs. J. Pharmacol. exp. Ther. 171, 256–264 (1970)

    Google Scholar 

  • Starke, K.: Influence of α-receptor stimulants on noradrenaline release. Naturwissenschaften 58, 420 (1971)

    Google Scholar 

  • Starke, K.: Alpha sympathomimetic inhibition of adrenergic and cholinergic transmission in the rabbit heart. Naunyn-Schmiedeberg's Arch. Pharmacol. 274, 18–45 (1972)

    Google Scholar 

  • Starke, K., Altmann, K. P.: Inhibition of adrenergic neurotransmission by clonidine: An action on prejunctional α-receptors. Neuropharmacology 12, 339–347 (1973)

    Google Scholar 

  • Starke, K., Endo, T., Taube, H. D.: Pre- and postsynaptic components in effect of drugs with α-adrenoceptor affinity. Nature (Lond.) 254, 440–441 (1975a)

    Google Scholar 

  • Starke, K., Montel, H., Endo, T.: Relative potencies of sympathomimetic drugs on pre- and postsynaptic adrenoceptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 287, R5 (1975b)

    Google Scholar 

  • Starke, K., Montel, H., Gayk, W., Merker, R.: Comparison of the effects of clonidine on pre- and postsynaptic adrenoceptors in the rabbit pulmonary artery. α-Sympathomimetic inhibition of neurogenic vasoconstriction. Naunyn-Schmiedeberg's Arch. Pharmacol. 285, 133–150 (1974a)

    Google Scholar 

  • Starke, K., Montel, H., Gayk, W., Merker, R.: Pre- and postsynaptic adrenoceptors in the rabbit pulmonary artery. Naunyn-Schmiedeberg's Arch. Pharmacol. 285, R 76 (1974b)

    Google Scholar 

  • Stjärne, L.: Mechanisms of catecholamine secretion. In: E. Usdin and S. H. Snyder (eds.): Frontiers in Catecholamine Research, pp. 491–496. New York-Toronto-Oxford-Sydney-Braunschweig: Pergamon 1973

    Google Scholar 

  • Su, C., Bevan, J. A.: The release of H3-norepinephrine in arterial strips studied by the technique of superfusion and transmural stimulation. J. Pharmacol. exp. Ther. 172, 62–68 (1970)

    Google Scholar 

  • Vizi, E. S., Somogyi, G. T., Hadházy, P., Knoll, J.: Effect of duration and frequency of stimulation on the presynaptic inhibition by α-adrenoceptor stimulation of the adrenergic transmission. Naunyn-Schmiedeberg's Arch. Pharmacol. 280, 79–91 (1973)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Starke, K., Endo, T. & Taube, H.D. Relative pre- and postsynaptic potencies of α-adrenoceptor agonists in the rabbit pulmonary artery. Naunyn-Schmiedeberg's Arch. Pharmacol. 291, 55–78 (1975). https://doi.org/10.1007/BF00510821

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00510821

Key words

Navigation